Understanding Gonococcal Arthritis Epidemiology
Official title: Epidemiology of Gonococcal Arthritis
Run by University Hospital, Brest · NCT06897943 · Data updated 2026-11-12
This study looks at the patterns and causes of gonococcal arthritis over the last ten years to see what factors might increase the risk and to understand the different strains of the bacteria involved.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 11 (estimated) |
| Sponsor | University Hospital, Brest Academic / other |
| Locations | 2 sites (Rennes, Brittany Region and 1 other locations) |
| Status | Recruiting |
| Started | December 1, 2024 |
| Main results expected | April 30, 2025 |
| Study ends | April 30, 2025 |
| Registry record updated | March 27, 2025 |
| Trial ID | NCT06897943 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include patients with a Neisseria gonorrhoeae-positive joint sample collected between 2014 and 2024.
✕Probably not a fit
Patients with a Neisseria gonorrhoeae-negative joint sample or those who oppose participation will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to analyze the epidemiology of Neisseria gonorrhoeae septic arthritis over the past decade at Brest and Rennes university hospitals. It focuses on identifying risk factors associated with the condition by examining clinical and epidemiological data. Additionally, the study seeks to characterize the gonococcal strains to determine the presence of common clones, virulence factors, or specific resistance genes.
Why it matters
Potential benefit: If successful, this study could enhance understanding of gonococcal arthritis, leading to improved prevention and treatment strategies.
How similar studies have gone: While this study focuses on a specific epidemiological aspect, similar studies have shown success in understanding infectious arthritis, making this approach promising.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with a Neisseria gonorrhoeae-positive joint sample (from an enrichment vial or a native sample) between 2014 and 2024. Exclusion Criteria: * Patients with Neisseria gonorrhoeae-negative joint sample (from enrichment vial or native sample). * Patients who have expressed opposition to inclusion in the study. * Patients under legal protection (guardianship, curatorship, etc.).
Where it's running
-
Rennes University Hospital
Rennes, Brittany Region, France Recruiting -
CHU de BREST
Brest, France Recruiting
Study contacts
- Principal investigator: Geneviève HERY-ARNAUD — CHU de Brest
- Study coordinator: Geneviève HERY-ARNAUD
- Email: genevieve.hery-arnaud@univ-brest.fr
- Phone: 0298145107
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Unified care and integrated treatments for ADHD with substance use in prison settings
Aimed at people under correctional supervision who have ADHD and substance use disorder, this program tests a coordinated care approach to improve identification and support.
-
4D dynamic LAFOV FDG-PET to tell leftover cancer from post-radiation inflammation in head and neck squamous cell carcinoma
This study will test whether a 4D dynamic long‑axial‑field‑of‑view FDG‑PET scan can tell remaining head and neck squamous cell cancer from normal post‑radiation inflammation in adults about three months after finishing curative radiotherapy.
-
Imaging the anatomy of the eye socket (orbit)
This project looks at existing orbital imaging from adults to see how the eye muscles, optic nerve, and orbital fat are arranged.
-
Combining European cohort data to find biomarkers that guide treatment for venous thromboembolism
This project combines clinical, biological and imaging data from European patient cohorts to try to find biomarkers that predict clot recurrence, bleeding, or death in people with venous thromboembolism.
-
Deneo Kid: an app to coordinate rehabilitation care for children and young people with neuromotor disabilities
This project will test whether the Deneo Kid app helps children and young people (age 2–25), their families, and rehabilitation teams share information and coordinate care more easily over three months.
-
Joint tissue analysis to understand rare and immunotherapy-related inflammatory arthritis
This project tests whether analyzing joint biopsy tissue can reveal distinct immune features in adults with inflammatory arthritis linked to rare autoimmune diseases or caused by cancer immunotherapy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.